Manufacturers Life Insurance Company, The Lexicon Pharmaceuticals, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 29,646 shares of LXRX stock, worth $19,862. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,646
Previous 48,048
38.3%
Holding current value
$19,862
Previous $75,000
72.0%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding LXRX
# of Institutions
133Shares Held
245MCall Options Held
52KPut Options Held
178K-
Artal Group S.A. Luxembourg, N4136MShares$91.2 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$26.1 Million1.27% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$6.63 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.88MShares$6.62 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct8.99MShares$6.02 Million0.02% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $126M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...